We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$442M
AUM Growth
+$27.8M
Cap. Flow
+$3.22M
Cap. Flow %
0.73%
Top 10 Hldgs %
55.81%
Holding
354
New
12
Increased
32
Reduced
43
Closed
5

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.09%
2 Technology 1.62%
3 Industrials 0.85%
4 Healthcare 0.49%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
76
Oracle
ORCL
$420B
$288K 0.07%
3,700
IBDQ
77
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$286K 0.06%
10,584
VOT icon
78
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20B
$282K 0.06%
1,193
IBDP
79
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$274K 0.06%
10,406
IBDR icon
80
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.39B
$269K 0.06%
10,105
IBDS icon
81
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
$265K 0.06%
9,779
IBDT icon
82
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
$263K 0.06%
9,096
IBDO
83
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$258K 0.06%
9,898
QCOM icon
84
Qualcomm
QCOM
$171B
$257K 0.06%
1,800
JNJ icon
85
Johnson & Johnson
JNJ
$613B
$252K 0.06%
1,530
MEAR icon
86
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.36B
$252K 0.06%
5,013
IBDN
87
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$252K 0.06%
9,936
IBDM
88
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$251K 0.06%
10,119
CVS icon
89
CVS Health
CVS
$133B
$250K 0.06%
3,000
FDX icon
90
FedEx
FDX
$73.2B
$239K 0.05%
800
ENB icon
91
Enbridge
ENB
$118B
$236K 0.05%
5,890
JPM icon
92
JPMorgan Chase
JPM
$937B
$234K 0.05%
1,504
PNC icon
93
PNC Financial Services
PNC
$100B
$229K 0.05%
1,200
PG icon
94
Procter & Gamble
PG
$345B
$221K 0.05%
1,640
IJT icon
95
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.52B
$220K 0.05%
1,659
+239
+17% +$31.1K
META icon
96
Meta Platforms (Facebook)
META
$1.5T
$208K 0.05%
597
VTEB icon
97
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$206K 0.05%
+3,724
New +$205K
VTWO icon
98
Vanguard Russell 2000 ETF
VTWO
$18B
$203K 0.05%
2,188
ADP icon
99
Automatic Data Processing
ADP
$107B
$199K 0.05%
1,000
-56
-5% -$10.9K
TIP icon
100
iShares TIPS Bond ETF
TIP
$14.5B
$199K 0.05%
1,558

Similar funds

Roble Belko & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Roble Belko & Company held 354 positions worth $442M, up 6.7% from $415M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 4.8%. Roble Belko & Company opened 12 new positions and exited 5, leaving the 354-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.1% of assets, down from 2.1% a quarter earlier, followed by Technology and Industrials.

  • Roble Belko & Company's largest Q2 2021 buy was Vanguard Ultra-Short Bond ETF: 29,147 shares worth $1.46M.
  • Roble Belko & Company added most to Vanguard International Dividend Appreciation ETF in Q2 2021, an estimated $3.27M increase.
  • Roble Belko & Company's biggest Q2 2021 reduction was Schwab US Broad Market ETF, cutting an estimated $2.16M.
  • Roble Belko & Company fully exited Valvoline in Q2 2021, selling an estimated $17K.
  • Roble Belko & Company's ten largest holdings make up 56% of its $442M portfolio in Q2 2021.
  • Roble Belko & Company opened 12 new positions and closed 5 in Q2 2021.
  • Roble Belko & Company's portfolio value rose 6.7% quarter-over-quarter to $442M.

Based on Roble Belko & Company's 13F filing for Q2 2021, filed 2 Aug 2021.